ChanTest offers cell-based assays to over 90 ion channel targets for screening and profiling for both early discovery and safety liability assessment. Both replicating and division-arrested cell lines are available for most targets which have been validated on a variety of automated electrophysiology platforms. ChanTest can also provide profiling, custom assay development and scale-up services according to customer specifications.